Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma
Year: 2005
Type: review
Abstract: Head and neck squamous cell carcinoma (HNSCC) involves the upper aerodigestive tract and can destroy the structure and function of organs involved in voice, speech, taste, smell and hearing, as well as vital structures necessary for survival. HNSCC has long been a treatment challenge because of the high rate of recurrences and of advanced disease at the time of diagnosis. Molecular identification of tissue biomarkers in diagnostic biopsy specimens may not only identify patients at risk for developing HNSCC but may also select patients that may benefit from more aggressive treatment modalities. Several biomarkers studied to date such as the proteins p53, cyclin D1, p16, Cox-2 enzyme, epidermal growth factor and vascular endothelial growth factor receptors, matrix metalloproteinases and the Fhit marker for genomic instability could be manipulated for the therapeutic benefit of these patients. This review presents the most updated information on molecular biomarkers with the greatest prognostic potential in HNSCC and discusses some factors that contribute to the controversy concerning their prognostic importance.
Institutions: University of Miami, University of Miami Health System
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Keywords: head and neck squamous cell carcinoma, molecular biomarkers, prognostic factors, clinical outcome prediction, p53, cyclin D1, p16, cyclooxygenase-2, epidermal growth factor receptor, vascular endothelial growth factor receptor, matrix metalloproteinases, FHIT, genomic instability, tumor recurrence, patient selection
Open Access status: green
Funder: University of Miami
OpenAlex ID: W1480254704
